Through Yun Biological (01332) intends to sell 70% equity of Weidao International for approximately RMB 13 million.

Zhtng Cijng APP News: Throughen Biology (01332) announced that on May 6, 2025, the seller (the Company's direct wholly-owned subsidiary Apex Capital Business Limited) intends to sell 70% of the total number of shares of the target company (Wayne International Limited) to the buyer (Renaissance Asia China Limited) for a total price of 13 million yuan.